Skip to content

Summit Therapeutics Inc.

SMMT· NasdaqCore metricsCIK 1599298

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -9.32%
Market cap
$12.06B
799.76M shares
Filings
568
$0.00
FY 2024
-$208.39M
Q3 2026N/M FY25 yoy
-$226.00M
FY 2024N/M FY24 yoy
-$424.78M
Q3 2026derivedN/M FY25 yoy
-$0.26
Q3 2026N/M FY25 yoy
$150.81M
Q3 2026+114.8% FY25 yoy
$12.06B
—
—
21.4×
-2.68%
—

FY2025 figures · derived

Price

$15.0821.34%$4.09past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2024
$57.09M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024
PeriodEndedValueKindSource trail
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20222022-12-31$705,000reported
FY 20212021-12-31$1,809,000reported
FY 20202020-12-31$860,000reported
FY 20192019-12-31$743,000reported
FY 20182019-01-31$57,088,000reported

Capital returns

Dividends and buybacks · FY2018 to FY2020
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2020$0.00—$0.00—82.92M sh−75.3%—
FY2019$0.00—$0.00—335.89M sh+356.6%—
FY2018$0.00—$0.00—73.56M sh——

Segments

Revenue by Geography, FY2019 to FY2022FY2019Latin America · FY2019 · $583.00KUnited States · FY2019 · $160.00KFY2020Latin America · FY2020 · $860.00KFY2021Latin America · FY2021 · $1.81MFY2022Latin America · FY2022 · $705.00K
LineFY2022ShareChange
Latin America$705.00K100%−61.0%
Europe———
United States———
Total$705.00K

From the 10-K filed Mar 9, 2023SMMT

Pharmaceutical preparations

Summit Therapeutics Inc. is the 29th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Summit Therapeutics Inc. · CIK 1599298 · Engraved from SEC EDGAR